THE EFFECT OF L- ARGININE ON OXIDATIVE STRESS AND MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE

L. P. Martynyuk, L. Z. Vons, O. O. Ruzhytska

Abstract


Background. One of the severest complications of diabetes is diabetic kidney disease (DKD). Microalbuminuria (MAU) is one of the first signals of DKD and an important pathogenetic mechanism of disease progression. With diabetes dramatically antioxidant properties worsen.

Objective. The aim was to investigate the effect of L-arginine on oxidative stress parameters and microalbuminuria in type 2 diabetes mellitus and chronic kidney disease patients.

Methods. Total of 57 patients with type 2 diabetes mellitus and chronic kidney disease and 30 healthy subjects (control group) were included in the study. The patients were divided into 2 congruent groups. The 1-st group of patients (n=33), in addition to standard therapy, received L-arginine 4.2 g intravenously for 5 days, after that they took it 1,0 g orally three times a day during meals for 1 month. The second group of patients (n=24) received a standard therapy.

The concentration of lipid peroxidation products was measured by a spectrophotometric method. The determination of MAU was carried out in morning portion of urine immunological semiquantitative using test strips.

Results. Significant improvement in indexes of lipid peroxidation was observed in both groups after therapy (p˂0.01), but in patients treated with L-arginine it was more expressed (p˂0,01). The standard therapy did not significantly affect the level of MAU (p˃0,05). The patients treated with L-Arginine, showed a significant reduction in MAU (p˂0.01).

Conclusions. The usage of L-arginine facilitates the correction of lipid peroxidation processes and reduces the severity of microalbuminuria in patients with diabetic kidney disease that slowing its progression.


Keywords


diabetes mellitus; chronic kidney disease; lipid peroxidation; microalbuminuria; L-arginine.

Full Text:

PDF

References


Schieppati A. Chronic renal disease as a public health problem: epidemiology, social and economic implications. Kidney Int. 2005;98:7–10.

Dudar I, Loboda O, Korol L, Alieksieieva V. Progression of chronic kidney disease and the role of oxidative stress in different stages of CKD. Ukrainian Journal of Nephrology and Dialysis. 2012;2(34):18–24.

Gaidaiev Yu. Endocrinological state service of Ukraine and prospects of medical care to patients with endocrine disorders. International Journal of Endocrinology. 2006;2(4):9–14.

Kamynsky A. Diabetes: new insights and old misconceptions. Part 2. Prevention of type 2 diabetes. International Journal of Endocrinology. 2012;4:42–45.

Kolesnyk M. Endocrinology: Science and Practice. Pharmacist. 2008;3:4–6.

Loboda OM, Krasyuk ІV, Alexeeva VV, Korol LV, Drіyanska VY, Dudar ІO. The relationship of lipid peroxidation and chronic inflammation of atherosclerotic changes in vessels and poeaznykamy endothelial dysfunction in patients with CKD stages II–IV. Ukrainian journal of Nephrology and dialysis. 2015;1(45):13–20.

Sirenko Yu. New Opportunities determination of microalbuminuria in clinical practice. Hypertension. 2010;3(11):55–58.

Caramori M. The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient. Diabetes. 2000;9:1399–1408.

Radzyshevsky N. Violation of homeostasis and oxidative carbohydrate metabolism and their effects on the heart and blood vessels in patients with comorbid diseases. Therapeutic Ukrainian magazine. 2016;1:30–35.

Reheda M, Bayda M. Role of disorders of lipid peroxidation and activity of antioxidant enzymes in the trachea of guinea pigs in the pathogenesis of allergic alveolitis ekspyrymentalnoho and their correction Thiotriazolin. Experimental and clinical physiology. 2013;1:47–52.

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150:604–612.

Gavrilov V, Mishkorudnaya M. Spectrophotometric determination of lipid hyperoxides in blood plasma. Laboratornoe delo. 1983;29:33–35.

Ellman GL. Tissue sulfhydryl groups. Arch Biochem. 1959;82:70–72.

Koroluy M, Ivanova L, Majorova I. Metod opredeleniya aktivnosti katalazi. Laboratornoe delo. 1988;34:16–19.

Chevari S, Andyal T, Shtrenger YA. Determination of antioxidant parameters of blood and their significance in old age. Laboratornoe delo. 1991;37:9–13.

Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol. 2001;12:1630–1639.

KanetsunaY, Takahashi K, Nagata M, Gannon MA, Breyer MD, Harris RC, et al. Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. Am J Pathol. 2007;170(5):1473–84.

Cherla G, Jaimes EA. Role of L-arginine in the pathogenesis and treatment of renal disease. J Nutr. 2004;134(10):2801–2806.

Claybaugh T, Decker S, McCall K, Slyvka Y, Steimle J, et al. L-Arginine Supplementation in Type II Diabetic Rats Preserves Renal Function and Improves Insulin Sensitivity by Altering the Nitric Oxide Pathway. Int J Endocrinol. 2014:171546. doi: 10.1155/2014/171546.




DOI: http://dx.doi.org/10.11603/ijmmr.2413-6077.2017.1.7867

Refbacks

  • There are currently no refbacks.